Finance
Beta
search
Search or ask
settings
Theme
mobile
Device default
✓
dark_mode
Dark theme
light_mode
Light theme
Search labs
feedback
Send feedback
Sign in
Lists
playlist_add
New
143860
Research
143860:KRX
check_indeterminate_small
Mirae Asset TIGER Health Care ETF
₩35,695.00
arrow_downward
-2.67%
(
-980.00
) 1D
Jul 13, 3:02:55 PM GMT+9 · KRW
area_chart
Area
stacked_line_chart
Compare
search
close
All symbols
monitoring
Indicators
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
Symbol
Price
Change
% Change
Overview
insights_auto
Generating top insights for 143860...
Open
₩36,480
High
₩37,500
Low
₩35,300
Avg. vol.
46.98K
Volume
54.35K
52-wk high
₩56,000
52-wk low
₩35,300
Open
₩36,480
High
₩37,500
Low
₩35,300
Avg. vol.
46.98K
Volume
54.35K
52-wk high
₩56,000
52-wk low
₩35,300
Related assets
244580
Samsung KODEX BIO ETF
₩8,205.00
-3.24%
arrow_downward
498050
NH-Amundi HANARO Bio Korea Active ETF
₩11,195.00
-3.07%
arrow_downward
292190
Samsung KODEX KRX300 ETF
₩48,900.00
-7.56%
arrow_downward
102110
Mirae Asset TIGER200 ETF
₩110,710.00
-8.24%
arrow_downward
News stories
From sources across the web
MarketBeat
·
7 minutes ago
Baidu, Inc. (NASDAQ:BIDU) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Trefis
·
28 minutes ago
S&P 500 Stocks At 52-Week Highs: Friday’s Full List
Stocktwits
·
1 hour ago
S&P 500 Can Hit 14,000 In 5 Years, Says Market Strategist — And 'You're Not Bullish Enough'
AOL.com
·
2 hours ago
SK Hynix slumps 13% after US debut euphoria
Show more
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer
Research
edit_square
New thread
notes_spark
Thread history
close
Collapse
expand_content
Expand
What's on your mind?
What's going on with the markets today?
search_spark
Explore what’s possible
add
Create portfolio
task_spark
Create a task
travel_explore
Deep Search
mic
Voice Search
add
Add Tool
upload_file
Upload File
bar_chart
Create portfolio
travel_explore
Deep Search
arrow_upward
Ask AI
search_spark
mic
Voice Search
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer